The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis.
primary studies published RCT
Details- 2011
- Amin R
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation.
primary studies published RCT
Details- 2011
- Bakker EM
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
primary studies published RCT
Details- 2011
- Bilton D
Timing of dornase alpha inhalation does not affect the efficacy of an airway clearance regimen in adults with cystic fibrosis: a randomised crossover trial.
primary studies published RCT
Details- 2011
- Bishop JR
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
primary studies published RCT
Details- 2011
- Borowitz D
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests.
primary studies published RCT
Details- 2011
- Castellani C
Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis.
primary studies published RCT
Details- 2011
- Coates AL
Enhancing self-efficacy for self-management in people with cystic fibrosis.
primary studies published RCT
Details- 2011
- Cummings E
Short-term effects of high-frequency chest compression and positive expiratory pressure in patients with cystic fibrosis.
primary studies published RCT
Details- 2011
- Fainardi V
Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects.
primary studies published RCT
Details- 2011
- Geller DE